Neuropsychobiology
Biological Psychiatry
Prevalence of Age Psychosis and Mortality among Age Psychotics in the Lundby StudyChanges over Time during a 25-Year Observation Period
Rorsman B.a · Hagnell O.a · Lanke J.b
aDepartment of Social and Forensic Psychiatry, and bDepartment of Statistics, University of Lund, Sweden
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: February 19, 2008
Issue release date: 1985
Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 0
ISSN: 0302-282X (Print)
eISSN: 1423-0224 (Online)
For additional information: https://www.karger.com/NPS
Abstract
It has been suggested that persons suffering from age psychosis have benefited from social and medical improvement in the society so that they live longer with their illness than they did before. The Lundby cohort comprises 3,563 persons from a total population, followed concerning mental disorders for 15 or 25 years. In the present study we have investigated the changes over time concerning prevalence of age psychosis and mortality among age psychotics in the Lundby Study during the 2 5-year observation period. When the first 10-year period was compared with the second 15-year period, the figures for average prevalence of age psychosis and death risk associated with a diagnosis of age psychosis had generally decreased in both sexes, but the differences found between the two time periods did not reach statistical significance. A significantly lower mortality during the second time period was found among mentally healthy women.
© 1985 S. Karger AG, Basel
Related Articles:
Article / Publication Details
Published online: February 19, 2008
Issue release date: 1985
Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 0
ISSN: 0302-282X (Print)
eISSN: 1423-0224 (Online)
For additional information: https://www.karger.com/NPS
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission